STS ⅡA inhibited angiogenesis of lung adenocarcinoma by activating FOXO3 to inhibit CXCL1/STAT3/VEGF pathway
Article in Toxicon (January 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Toxicon (January 2024)
Article in International Journal of Molecular Sciences (November 2023)
Article in Frontiers in Pharmacology (October 2023)